Linear programming was combined with cost effectiveness studies, county demographics and epidemiologic data related to CVD and three cancers (Breast, Cervical, and Colorectal) to identify the most efficient allocation of prevention resources in South Carolina. The model distributes resources across county, age, gender, race, risk factors and interventions. The algorithms maximize the life years gained as a result of additional resources.
Findings from a model limited to CVD yielded the following:
Table 1:
|
|
|
||
Full Funding - $606,825,000 |
1,397,260
|
|
$23,812
|
|
50% - $303,412,500 |
719,745
|
|
$13,438
|
|
5% - $30,000,000 |
88,165
|
5,932
|
$5,057
|
Additional constraints change the distribution of resources and the efficiency of the dollar allocation. Table 2 shows the efficiency loss associated with the different constraints when allocating $30,000,000.
Table 2:
|
|
|
||
Unconstrained |
88,165
|
5,932
|
$5,057
|
|
Proportional by County |
87,763
|
5,922
|
$5,066
|
|
Proportional by Race |
91,341
|
5,868
|
$5,112
|
|
Proportional by Gender |
93,499
|
5,667
|
$5,294
|
|
Equal by Gender |
93,499
|
5,627
|
$5,331
|
|
Equal by County |
89,851
|
5,535
|
$5,420
|
The allocation model developed in this study can provide policy makers with the ability to assess the impact of different resource allocation mechanisms. In addition, the model can be used to assess the value – in life years – of different decisions or constraints on the allocation of additional resources.
Learning Objectives: At the conclusion of the session, the participant (learner) in this session will: 1.Understand the use of linear programming as an extension of cost effectiveness analysis. 2.Assess the efficieny and distributional effects of distributing funds for the prevention of cardiovascular disease and cancer
Keywords: Economic Analysis, Methodology
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.